Yosuke Koroki

9PUBLICATIONS
31CO-AUTHORS
Medical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical biochemistry - proteins and peptides (incl. medical proteomics)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 26, 2025
Correlation between duration of first-line treatment with daratumumab, lenalidomide, and dexamethasone and overall survival in patients with transplant-ineligible multiple myeloma in Japan.

Kazuhito Suzuki, Miku Ito, Chika Sakai

|Sep 12, 2025
Impact of best response to ibrutinib plus Bendamustine and rituximab on PFS in MCL: a secondary analysis of SHINE.

Yuko Mishima, Daigo Hashimoto, Michiko Ichii

|May 14, 2025
Real-World Treatment Outcomes of Different Sequencing Options with Daratumumab, Lenalidomide, and Dexamethasone in Patients with Transplant-Ineligible Multiple Myeloma in Japan.

Kazuhito Suzuki, Yuma Fujimori, Chika Sakai

|Jun 28, 2024
Apalutamide and Goserelin for Androgen Receptor-Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASU.

Yoshitaka Honma, Nobuya Monden, Keisuke Yamazaki

|Nov 28, 2022
Clinical Outcomes of First Subsequent Therapies After Abiraterone Acetate Plus Prednisone for High-Risk Metastatic Castration-Sensitive Prostate Cancer in the LATITUDE Study.

Yosuke Koroki, Masataka Taguri

|Aug 26, 2022
Treatment strategies and outcomes in a long-term registry study of patients with high-risk metastatic hormone-naïve prostate cancer in Japan: An interim analysis of the J-ROCK study.

Hirotsugu Uemura, Rikiya Matsumoto, Atsushi Mizokami

Pageof 2

Frequent Collaborators

2 joint publications

Miku Ito

2 joint publications

Hiroaki Tsuchiya

2 joint publications

Chika Sakai

2 joint publications

Kazuhito Suzuki